orforglipron vs retatrutide Lilly oral GLP-1 phase 3 weight loss trial PDB-101: Molecule of the Month:

Milton Packer, the study found that tirzepatide reduced the combined risk of cardiovascular death or worsening heart failure by 38% (HR 0.62) over a median of 104 weeks

Moore said Ozempic total prescriptions were "flattish" and that patients were switching from Ozempic to a competitor, comments that contrasted with the company's broader second-half expectations communicated in May

Monitor Symptoms and Labs Medical monitoring matters because weight-loss medications can affect digestion, hydration, glucose levels, appetite, and medication needs

When researchers added cyclodextrin absorption enhancers, specifically dimethyl-beta-cyclodextrin at concentrations of just 2% w/v, nasal peptide bioavailability in animal models jumped to 70-100%

Glucose Stimulated Insulin Secretion (GSIS) For in vitro static GSIS, digestion and islet isolation was performed as previously described 1, 15, 16 for each condition

Evening Injection: Potential Advantages and Considerations Injecting semaglutide before bed offers logistical convenience for people with busy daytime schedules